Efficacy of pro‐haemostatic agents in the management of factor Xa inhibitor‐associated intracranial haemorrhages
Patients who presented with intracranial haemorrhages in the presence of clinically significant direct oral anticoagulant levels had a higher risk of mortality that does not appear to change with the use of prohaemostatic agents. The efficacy of prohaemostatic agents may not be as clinically significant based on real-world experience in contrast to previously reported studies.
Authors
- Danny Hsu (ORCID: https://orcid.org/0000-0002-9577-5401)
- Diem Thi Nguyen (ORCID: https://orcid.org/0000-0002-9680-5772)
- Zhiwei Wang (ORCID: https://orcid.org/0000-0001-5643-9344)
- Sara Ng (ORCID: https://orcid.org/0000-0002-5620-1659)
- Homa Noori
Institutions
- Liverpool Hospital (AU)
- UNSW Sydney (AU)
- South Western Sydney Local Health District (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1111/imj.70074
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- University of New South Wales
- Novo Nordisk